Moderna Inc. buy WatchMen
Start price
25.11.20
/
50%
€91.45
Target price
25.11.21
€180.00
Performance (%)
161.40%
End price
26.11.21
€239.05
Summary
This prediction ended on 26.11.21 with a price of €239.05. The BUY prediction by WatchMen for Moderna Inc. saw massive gains of 161.40%. WatchMen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Moderna Inc. | -6.429% | -6.429% | -36.741% | -81.158% |
iShares Core DAX® | -0.372% | 5.236% | 16.908% | 16.016% |
iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% | 31.832% |
iShares Nikkei 225® | -1.690% | 7.286% | 12.202% | 3.400% |
iShares S&P 500 | -0.399% | 2.379% | 20.975% | 36.224% |
According to WatchMen what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small Risks for its business
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by WatchMen for this prediction
In the thread Moderna Inc. diskutieren
Buy mit Kursziel 120,0
Kursziel geändert auf 140,0
Kursziel geändert auf 180,0
In the thread Trading Moderna Inc.
Die von WatchMen gewählte maximale Laufzeit wurde überschritten
Stopped prediction by WatchMen for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€97.01
24.03.24
24.03.24
€130.00
24.03.25
24.03.25
-28.34%
01.09.24
01.09.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Moderna Inc.
Start price
Target price
Perf. (%)
€126.14
21.02.22
21.02.22
-
21.02.23
21.02.23
19.31%
22.02.23
22.02.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Moderna Inc.
Start price
Target price
Perf. (%)
€66.08
16.11.20
16.11.20
-
16.11.21
16.11.21
-
16.11.20
16.11.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Moderna Inc.
Start price
Target price
Perf. (%)
€80.67
16.11.20
16.11.20
-
16.11.21
16.11.21
0.36%
16.11.20
16.11.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected